Gilead to pay $97 million to resolve kickback claims -U.S. Justice Department

Credit: REUTERS/Mike Blake

WASHINGTON, Sept 23 (Reuters) - Gilead Sciences Inc GILD.O has agreed to pay $97 million to resolve claims that it illegally used a foundation as a conduit to pay the copays of thousands of Medicare patients taking Gilead's pulmonary arterial hypertension drug Letairis, the Justice Department said on Wednesday.

(Reporting by Mohammad Zargham)


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.